Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 277.2M
Gross Profit 227.8M 82.17%
Operating Income -4.1M -1.49%
Net Income 27.3M 9.85%

Balance Sheet Metrics

Total Assets 986.3M
Total Liabilities 389.5M
Shareholders Equity 596.8M
Debt to Equity 0.65

Cash Flow Metrics

Operating Cash Flow 70.0M
Free Cash Flow 60.2M

Revenue & Profitability Trend

Dynavax Technologies Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue277.2M232.3M722.7M439.4M46.6M
Cost of Goods Sold49.4M50.2M262.2M173.6M13.9M
Gross Profit227.8M182.1M460.5M265.9M32.6M
Operating Expenses231.9M207.8M178.0M132.4M107.9M
Operating Income-4.1M-25.7M282.5M133.5M-75.2M
Pre-tax Income30.9M-4.4M294.3M77.5M-75.2M
Income Tax3.5M2.0M1.1M808.0K0
Net Income27.3M-6.4M293.2M76.7M-75.2M
EPS (Diluted)--$0.05$1.97$0.57-$0.78

Income Statement Trend

Dynavax Technologies Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets848.9M859.1M917.0M972.5M290.0M
Non-Current Assets137.3M138.0M68.9M66.7M63.3M
Total Assets986.3M997.1M985.8M1.0B353.3M
Liabilities
Current Liabilities78.6M62.2M150.1M556.4M77.4M
Non-Current Liabilities310.8M312.8M254.8M260.5M217.2M
Total Liabilities389.5M375.0M404.8M816.9M294.6M
Equity
Total Shareholders Equity596.8M622.1M581.0M222.4M58.7M

Balance Sheet Composition

Dynavax Technologies Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income27.3M-6.4M293.2M76.7M-75.2M
Operating Cash Flow70.0M90.7M-66.5M305.1M-53.2M
Investing Activities
Capital Expenditures-6.4M-4.1M-7.1M-9.5M-4.1M
Investing Cash Flow-18.0M-154.9M-317.0M13.2M-26.4M
Financing Activities
Dividends Paid-----
Financing Cash Flow-109.3M-6.5M030.5M108.5M
Free Cash Flow60.2M96.5M55.6M326.1M-103.3M

Cash Flow Trend

Dynavax Technologies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 54.60
Forward P/E 29.39
Price to Book 2.47
Price to Sales 4.31
PEG Ratio 29.39

Profitability Ratios

Profit Margin -20.39%
Operating Margin -31.40%
Return on Equity -10.45%
Return on Assets -0.07%

Financial Health

Current Ratio 11.93
Debt to Equity 54.64
Beta 1.04

Per Share Data

EPS (TTM) -$0.50
Book Value per Share $4.29
Revenue per Share $2.29

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
dvax1.3B54.602.47-10.45%-20.39%54.64
Zoetis 70.3B28.3415.1252.09%27.12%145.63
Haleon Plc - ADR 45.5B23.375.638.95%12.84%63.41
Supernus 1.8B28.911.776.32%9.27%3.13
Indivior PLC 1.9B530.50-6.57-0.57%-5.30%-1.29
Bausch Health 2.6B-50.69-9.9514.29%-0.41%-89.63

Financial data is updated regularly. All figures are in the company's reporting currency.